Search
for

    Sort by

    Research 361–390 of 1000+

    1. Major role for 5-alpha reductase inhibitors in the aging male Canadian Urological Association Journal · 2012
    2. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. PubMed · 2026
    3. Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders ACS Omega · 2023
    4. HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond Endocrinology · 2019 · 30 citations
    5. Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms Phytomedicine plus · 2021 · 1 citations
    6. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study Urology · 2023 · 2 citations
    7. Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review Revista Eletrônica Acervo Médico · 2022
    8. 5α‐Reductase Inhibitors 2014
    9. HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2) Biomedical Journal of Scientific & Technical Research · 2024
    10. This Month in Adult Urology 2018
    11. Structure of human type II 5 alpha-reductase gene Endocrinology · 1992 · 76 citations
    12. Analytical methods of dutasteride: An overview Annals of phytomedicine · 2023
    13. 5 Alpha-reductase inhibitors: whatʼs new? Current opinion in urology · 2003 · 47 citations
    14. 5-alpha reductase inhibitors use in prostatic disease and beyond Translational Andrology and Urology · 2023
    15. Using 5 alpha reductase inhibitors safely: What primary care physicians need to know Journal of Family Medicine and Primary Care · 2024
    16. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    17. Reply to finasteride and dutasteride may reduce melanoma risk Cancer · 2015 · 1 citations
    18. 5α-Reductase: History and Clinical Importance PubMed Central · 2004 · 20 citations
    19. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    20. BPH: epidemiology and comorbidities. PubMed · 2006 · 386 citations
    21. 5alpha-reductase: history and clinical importance. PubMed · 2004 · 62 citations
    22. Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function Current Urology Reports · 2014 · 11 citations
    23. BPH Medications May Increase Risk of Self-Harm, Depression Psychiatric news · 2017
    24. New Drugs: Dutasteride Australian Prescriber · 2009
    25. Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men Annals of Internal Medicine · 2014
    26. Finasteride and dutasteride may reduce melanoma risk Cancer · 2015
    27. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    28. Saw Palmetto (Serenoa repens) Elsevier eBooks · 2021
    29. Efficacy of Combination of Tamsulosin and Finasteride on Urinary Symptoms and IPSS Score for Elderly Patients with BPH Hebei yixue · 2014
    30. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003 · 90 citations